These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19176460)

  • 21. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
    Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
    Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
    Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study].
    Rubio Suárez A; Teigeiro Núñez V; Gallo Terán J; Señaris González B; Mesuro Domínguez N
    Acta Otorrinolaringol Esp; 2003 Dec; 54(10):697-703. PubMed ID: 15164709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited.
    Wolf GT
    Head Neck; 2010 Jan; 32(1):7-14. PubMed ID: 19953621
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
    Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
    Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the role of primary surgery in the treatment of laryngeal and hypopharyngeal cancer? Hayes Martin Lecture.
    Lefebvre JL
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):285-8. PubMed ID: 10721998
    [No Abstract]   [Full Text] [Related]  

  • 27. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.
    Lefebvre JL; Pointreau Y; Rolland F; Alfonsi M; Baudoux A; Sire C; de Raucourt D; Malard O; Degardin M; Tuchais C; Blot E; Rives M; Reyt E; Tourani JM; Geoffrois L; Peyrade F; Guichard F; Chevalier D; Babin E; Lang P; Janot F; Calais G; Garaud P; Bardet E
    J Clin Oncol; 2013 Mar; 31(7):853-9. PubMed ID: 23341517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
    Daly ME; Le QT; Jain AK; Maxim PG; Hsu A; Loo BW; Kaplan MJ; Fischbein NJ; Colevas AD; Pinto H; Chang DT
    Head Neck; 2011 Jan; 33(1):103-11. PubMed ID: 20848427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
    Haddad RI
    J Natl Cancer Inst; 2009 Aug; 101(16):1157-8; author reply 1158. PubMed ID: 19567423
    [No Abstract]   [Full Text] [Related]  

  • 34. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
    Lefebvre JL; Ang KK;
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Partial surgery in treatment of cancers of the piriform sinus and lateral epilarynx].
    Piquet JJ; Chevalier D; Thill C
    Arch Otorhinolaryngol Suppl; 1991; 1():47-53. PubMed ID: 1867572
    [No Abstract]   [Full Text] [Related]  

  • 36. Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review.
    Bova R; Goh R; Poulson M; Coman WB
    Laryngoscope; 2005 May; 115(5):864-9. PubMed ID: 15867655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of chemotherapy in the curative treatment of head and neck cancer.
    Pfister DG; Shaha AR; Harrison LB
    Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
    Semrau S; Waldfahrer F; Lell M; Linke R; Klautke G; Kuwert T; Uder M; Iro H; Fietkau R
    Strahlenther Onkol; 2011 Jan; 187(1):15-22. PubMed ID: 21234526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Functional organ preservation in laryngeal and hypopharyngeal cancer].
    Ambrosch P; Fazel A
    Laryngorhinootologie; 2011 Mar; 90 Suppl 1():S83-109. PubMed ID: 21523635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Collision tumor of a hypopharyngeal adenoidcystic carcinoma and a laryngeal squamous cell carcinoma].
    Kufeld M; Junker K; Sudhoff H; Dazert S
    Laryngorhinootologie; 2004 Jan; 83(1):51-4. PubMed ID: 14740306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.